Skin autofluorescence is elevated in neovascular age-related macular degeneration

British Journal of Ophthalmology

Volumn 94, Issue 5, 2010, Pages 622-625

  Mulder, D J ^a   Bieze, M ^a   Graaff, R ^a   Smit, A J ^a   Hooymans, J M M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

AGED; ARTICLE; AUTOFLUORESCENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RISK FACTOR; SKIN;

AGED; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; CHOROIDAL NEOVASCULARIZATION; CROSS-SECTIONAL STUDIES; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; SKIN;

EID: 77952133585     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.162990     Document Type: Article

References (24)

1. de Jong PT. Age-related macular degeneration. N Engl J Med 2006;355:1474-1485
2. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001;20:227-253 (Pubitemid 32149928)
3. Crabb JW, Miyagi M, Gu X, et al. From the cover: drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 2002;99:14682-14687 (Pubitemid 35334544)
4. Mullins RF, Russell SR, Anderson DH, et al. Drusen associated with aging and agerelated macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000;14:835-846
5. Seddon JM, George S, Rosner B, et al. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 2005;123:774-782 (Pubitemid 41056598)
6. Snow KK. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol 1999;6:125.
7. Clemons TE, Milton RC, Klein R, et al. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report no. 19. Ophthalmology 2005;112:533-539 (Pubitemid 41626684)
8. Smit AJ, Lutgers HL. The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation. Curr Med Chem 2004;11:2767-2784
9. Stitt AW. The Maillard reaction in eye diseases. Ann N Y Acad Sci 2005;1043:582-597
10. Mulder DJ, Water TV, Lutgers HL, et al. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006;8:523-535
11. Meerwaldt R, Oomen PHN, Links TP, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-1330
12. Meerwaldt R, Graaff R, Links T, et al. Skin autofluorescence, a noninvasive measure of advanced glycation end product accumulation, is a predictor of mortality in hemodialysis patients. Ann N Y Acad Sci 2005;1043:911.
13. Mulder DJ, van Haelst PL, Gross S, et al. Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis 2008;197:217-223
14. Meerwaldt R, Lutgers HL, Links TP, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007;30:107-112
15. Seddon JM, Willett WC, Speizer FE, et al. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996;276:1141-1146
16. Age-Related Eye Disease Study Research Group. A randomized, placebocontrolled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-1436
17. Hammes HP, Hoerauf H, Alt A, et al. N(epsilon)(carboxymethyl)lysine and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest Ophthalmol Vis Sci 1999;40:1855-1859.
18. Okubo A, Rosa RH Jr, Bunce CV, et al. The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci 1999;40:443-449
19. Hartog J, de Vries A, Lutgers H, et al. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann N Y Acad Sci 2005;1043:299-307.
20. Cerami C, Founds H, Nicholl I, et al. Tobacco smoke is a source of toxic reactive glycation endproducts. Proc Natl Acad Sci U S A 1997;94:13915-13920
21. Koschinsky T, He CJ, Mitsuhashi T, et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A 1997;94:6474-6479
22. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001;108:697-704.
23. Schmitz-Valckenberg S, Fleckenstein M, Scholl HP, et al. Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmol 2009;54:96-117.
24. Wilson HL, Schwartz DM, Bhatt HR, et al. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with agerelated macular degeneration. Am J Ophthalmol 2004;137:615-624